{
    "Trade/Device Name(s)": [
        "Tag-It\u2122 Cystic Fibrosis Kit"
    ],
    "Submitter Information": "Tm Bioscience Corporation",
    "510(k) Number": "K060627",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043011"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NUA"
    ],
    "Summary Letter Date": "June 7, 2006",
    "Summary Letter Received Date": "March 15, 2006",
    "Submission Date": "March 8, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.5900"
    ],
    "Regulation Name(s)": [
        "CFTR (cystic fibrosis transmembrane conductance regulator) gene mutation detection system"
    ],
    "Analyte Class(es)": [
        "genetic molecular"
    ],
    "Analyte(s)": [
        "CFTR gene mutations and variants"
    ],
    "Specimen Type(s)": [
        "Human blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Multiplex PCR",
        "Multiplex ASPE (Allele-Specific Primer Extension)",
        "Fluorescent bead-based detection"
    ],
    "Methodologies": [
        "Qualitative genotyping",
        "Mutation detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Software",
        "Multiplex",
        "Reagent",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Tag-It\u2122 Cystic Fibrosis Kit for qualitative genotyping of CFTR gene mutations and variants in human blood using multiplex PCR and bead-based detection",
    "Indications for Use Summary": "Used to detect and identify a panel of CFTR gene mutations and variants in human blood for carrier testing in adults of reproductive age, newborn screening, and confirmatory diagnostic testing in newborns and children; not indicated for fetal or pre-implantation testing or stand-alone diagnostics",
    "fda_folder": "Immunology"
}